Intelligent Bio Solutions Inc. has recently unveiled groundbreaking data that solidifies the security and performance of its Intelligent Fingerprinting Drug Screening System, bolstering its FDA 510(k) submission. The company conducted rigorous cybersecurity testing, including penetration testing and electromagnetic compatibility testing, to ensure the reliability and accuracy of its technology. Utilizing advanced quantification techniques, such as human eccrine sweat testing, Intelligent Bio Solutions has demonstrated its capability to detect trace sweat volumes at an ultra-micro level. By employing an Ultra-Micro Balance scale, the company can measure minuscule amounts of sweat in a single fingerprint, highlighting the precision and sensitivity of its technology. This innovative tool can detect volumes as light as 0.0000001 grams, showcasing its unparalleled accuracy. As Intelligent Bio Solutions prepares for its 510(k) resubmission, the focus remains on addressing FDA inquiries and enhancing the submission’s quality. With extensive input from regulatory consultants and FDA specialists, the company’s R&D team has dedicated over 6,000 hours to testing, data analysis, and technical reporting, underscoring its commitment to excellence in biotechnology.
Read more from benzinga.com